Research and Markets and Trimark Invite You to the Point of Care Testing Conference 2007 in New York City on October 22nd.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c67639) has announced the addition of "The Point of Care Testing Conference 2007" to their offering. Research & Markets and Trimark invite you to a one-day conference The Point of Care Testing Conference 2007 in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. on October 22nd "Point of Care Testing: Innovation on the Move, From Nanotechnology to Personalized Medicine  The external links in this article or section may require cleanup to comply with Wikipedia's content policies. "
The Conference will be held on Monday, October 22, 2007 at The Princeton Club of New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of located at 15 West 43rd Street (between Fifth and Sixth Avenues) New York, New York. Key Themes: - A critical examination of key emerging technologies applicability to point of care. - Formation of successful alliances. - Partnering of emerging technologies with point of care diagnostics. - Transitioning from laboratory in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. to point of care diagnostics. Questions Answered in the Conference: -What will the POC (Proof Of Concept) See PoC exploit. POC - Point Of Contact market be worth by the end of the decade? -Which market segments will drive POC market growth? -Which new technologies will reach the POC market in the next 2-3 years? -How is technology innovation impacting the dynamics and ownership of the POC -industry? -What are the key challenges in gaining acceptance of new technologies by users, -payers and regulators? -How is technology innovation facilitating the transition of POC testing into standard healthcare practice? Who Should Attend: Point of care companies. In vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic companies. Biotechnology companies. Medical device manufacturers. Leaders from the Following Areas Will Greatly Benefit from Attending: Laboratory leaders. Hospital CFOs and CSOs. Point of care and in vitro diagnostic companies. Business development. Strategic planning and development. Technology development. Marketing. Research and development. Overview: The Point of Care Diagnostics 2007 Conference has been organized to provide a critical examination of the point of care industry, as well as insight from key industry leaders concerning cutting edge point of care technology, structuring mutually beneficial deals and the point of care industry's impact on the field of in vitro diagnostics. This conference will also provide an integral forum for leaders in point of care, in vitro diagnostics and laboratories to share ideas, network with other delegates and advance understanding of the potential of new point of care technologies. The Conference will be a gathering of global companies leading the way in point of care testing and will include presentations from POC industry experts such as: -Keynote Speaker James Nichols, Ph.D., Tufts University School of Medicine The Tufts University School of Medicine is one of the eight schools that comprise Tufts University. Located on the university's health sciences campus in the Chinatown district of Boston, Massachusetts, the medical school has clinical affiliations with thousands of doctors and , Bay State Medical Center, discussing "Integrating Point of Care Testing in Healthcare Facilities". -Richard Egan, Ph.D., Nanogen, Inc., discussing "Bringing Advanced Diagnostics to the Bedside". -Bob Kunkler, Divisional Vice President, Abbott Point of Care, discussing "Diagnosis and Treatment in Place". -Sheldon Campbell, M.D., Ph.D., Yale School of Medicine The primary teaching hospital for the school is Yale-New Haven Hospital. The school is home to the Harvey Cushing/John Hay Whitney Medical Library, one of the largest modern medical libraries, also known for its historical collections. , discussing "Teaching Point of Care to Our Next Generation of Physicians". -Arnold Kaldowski, Ph.D., Senior VP of Point of Care, Siemens Medical Solutions Siemens Medical Solutions (Siemens Med) is a supplier to the healthcare industry, and is headquartered in Erlangen, Germany. Its U.S. division, Siemens Medical Solutions USA, Inc., is a Delaware corporation, with headquarters in Malvern, Pennsylvania. Diagnostics, discussing "Point of Care Industry Overview and Future Prospects". -Larry Kricka, Ph.D., FACB FacB Facilitair Bedrijf (Dutch) FACB Fellow of the National Academy of Clinical Biochemistry FACB Funk Amateur Club Basel (German: Radio Amateur Club Basel, Switzerland) , University of Pennsylvania (body, education) University of Pennsylvania - The home of ENIAC and Machiavelli. http://upenn.edu/. Address: Philadelphia, PA, USA. Medical Center, discussing "The Future Is Now: The Role of Technological Innovation and The Impact of Molecular Diagnostics and Microarrays on POC". -Harry Glorikian, Managing Partner, Scientia Advisors, discussing "Point of Care Diagnostics and Technology". -Joseph Dooley, Ph.D., Chief Executive Officer, TriMark Publications, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control discussing "Business Changes in the Point of Care Testing Sector: What's Happening and Why". Registration Fees for the Conference: -Early-Bird Registration Fee (before Sept. 28, 2007) is EU553.* *This is a special price of EU553 until September 28th, after which the fee will be increased. For more information visit http://www.researchandmarkets.com/reports/c67639 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion